Stay updated on AMX0035 in ALS: Phoenix Clinical Trial
Sign up to get notified when there's something new on the AMX0035 in ALS: Phoenix Clinical Trial page.

Latest updates to the AMX0035 in ALS: Phoenix Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe record now presents details of the Phase III AMX0035 trial for amyotrophic lateral sclerosis, including its eligibility criteria, study locations, treatment arms, and outcome measures.SummaryDifference73%

- Check15 days agoChange DetectedThe footer now displays site revision v3.8.0 instead of v3.7.2, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check22 days agoChange DetectedA sitewide notice announces an NIH transition from “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.SummaryDifference1%

- Check29 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2. The page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check36 days agoChange DetectedThe site revision label in the footer changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.SummaryDifference0.2%

- Check50 days agoChange DetectedThe study details page now displays a 403 Forbidden error, replacing the previous content. Access to the study record is blocked.SummaryDifference0.5%

Stay in the know with updates to AMX0035 in ALS: Phoenix Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AMX0035 in ALS: Phoenix Clinical Trial page.